Jun 21, 2021 Aethlon Medical to Release Fourth Quarter Financial Results and Host Conference Call on June 24, 2021
Jun 10, 2021 Aethlon Medical Announces $12.425 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
Jun 3, 2021 Aethlon Medical Publishes Case Studies of Two Critically Ill COVID-19 Patients Treated with the Hemopurifier®
Feb 4, 2021 Aethlon Medical to Release Third Quarter Financial Results and Host Conference Call on February 10, 2021
Jan 6, 2021 Aethlon Medical Expands Leadership Team with Appointment of Chief Business Officer and Chief Medical Officer
Dec 16, 2020 Aethlon Medical Announces First Patient Treated in First-in-Human Clinical Trial of HEMOPURIFIER® in Head and Neck Cancer
